- Home
- HMY vs ELAN Comparison
HMY vs ELAN Comparison
Compare HMY & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMY | ELAN |
|---|---|---|
| Founded | 1950 | 1954 |
| Country | South Africa | United States |
| Employees | 34350 | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 11.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HMY | ELAN |
|---|---|---|
| Price | $13.40 | $24.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $16.00 | ★ $27.63 |
| AVG Volume (30 Days) | 4.0M | ★ 4.6M |
| Earning Date | 02-04-2016 | 05-06-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $40.34 | $8.61 |
| Revenue Next Year | $22.08 | $4.90 |
| P/E Ratio | $15.60 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $12.50 | $8.02 |
| 52 Week High | $26.04 | $27.72 |
Technical Indicators
Market Signals| Indicator | HMY | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 24.56 | 47.34 |
| Support Level | N/A | $23.72 |
| Resistance Level | $15.65 | $25.68 |
| Average True Range (ATR) | 0.76 | 0.92 |
| MACD | -0.58 | 0.03 |
| Stochastic Oscillator | 4.60 | 50.80 |
Price Performance
Historical ComparisonAbout HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.